MicroAMP tube

[{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b84/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b84/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b83/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b83/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b82/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b82/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b81/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b81/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b80/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b80/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b7f/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b7f/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b7e/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b7e/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b7d/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b7d/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b7c/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b7c/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b7b/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b7b/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b7a/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b7a/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b79/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b79/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b78/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b78/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b77/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b77/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b76/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b76/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b75/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b75/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b74/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b74/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b73/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b73/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b72/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b72/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b71/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b71/5ca22b626f3d693300ae2b6e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca22c836f3d693300ae2b70/5ca22b626f3d693300ae2b6e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca22c836f3d693300ae2b70/5ca22b626f3d693300ae2b6e.png"}]